We are live on ! Find out more
DRGS

RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS
DRGS

Delisted

DRGS was delisted on the 6th of July, 2015.

Back to rankings

1 hedge funds and large institutions have $10K invested in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS in 2013 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
U
UBS
Switzerland
+$9.73K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
U
1
UBS
Switzerland
$10K +$9.73K +248 New

DRGS Hedge Fund Activity: Q4 2013 in Review

1 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) for Q4 2013, worth a combined $10K.

Buyers outnumbered sellers: 1 fund opened new DRGS positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS, opening a new position worth an estimated $9.73K.

  • 1 institutional investor held RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) as of Q4 2013, up from 0 in Q3 2013.
  • Funds reported $10K of RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS stock for Q4 2013.
  • 1 fund opened new RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS positions in Q4 2013 and 0 closed out, a net change of +1 holder.
  • The largest RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS buyer in Q4 2013 was UBS, an estimated $9.73K added.

Based on aggregated 13F filings for Q4 2013.